PMID: 8944768Nov 1, 1996Paper

Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9

European Journal of Biochemistry
Pascale JeanJ A Goldstein

Abstract

Oxidation of tienilic acid by human cytochromes P-450 (CYP) 2C9, 2C18, 2C8 and 2C19 was studied using recombinant enzymes expressed in yeast. CYP 2C9 was the best catalyst for 5-hydroxylation of tienilic acid (K(m) = 5 +/- 1 microM, kcat = 1.7 +/- 0.2 min-1), 30-fold more potent in terms of kcat/K(m) than CYP 2C18 (K(m) = 150 +/- 15 microM, kcat = 1.8 +/- 0.2 min-1) and 300-fold more potent than CYP 2C8 (K(m) = 145 +/- 15 microM, kcat = 0.2 +/- 0.1 min-1). CYP 2C19 was unable to catalyze this hydroxylation under our experimental conditions. During this study, a marked effect of the ionic strength on the activities (hydroxylations of tienilic acid and tolbutamide) of these cytochromes P-450 expressed in the yeast strain 334 was observed. The effect was particularly great in the case of CYP 2C18, with a tenfold decrease of activity upon increasing ionic strength from 0.02 to 0.1. Specific-covalent binding of tienilic acid metabolites to cytochrome P-450 (incubations in the presence of 5 mM glutathione) was markedly higher upon tienilic acid oxidation by CYP 2C9 than by CYP 2C18 and CYP 2C8. Mechanism-based inactivation of cytochrome P-450 during tienilic acid oxidation was observed in the case of CYP 2C9 but was not detectable wi...Continue Reading

References

Jan 1, 1978·Methods in Enzymology·H W Strobel, J D Dignam
Nov 15, 1991·Archives of Biochemistry and Biophysics·K M KedzieJ R Halpert
Nov 15, 1990·Biochemical and Biophysical Research Communications·S J PerneckyM J Coon
Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P BeauneJ C Homberg
Mar 1, 1980·The Biochemical Journal·S G Waley
Jan 1, 1980·European Journal of Drug Metabolism and Pharmacokinetics·P VinayM Bertrand
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Jan 1, 1995·Methods in Enzymology·R B Silverman
Feb 22, 1994·Biochemistry·J A GoldsteinB I Ghanayem
Jan 1, 1994·Drug Metabolism and Drug Interactions·P UrbanD Pompon

❮ Previous
Next ❯

Citations

Mar 17, 2004·Archives of Pharmacal Research·Sang-Kwang LeeYoung-Jin Chun
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·S EkinsS A Wrighton
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Shufeng Zhou
Aug 25, 2012·Journal of Chemical Information and Modeling·Valérie Campagna-SlaterNicolas Moitessier
Apr 3, 2012·Chemical Research in Toxicology·Yakov M KoenRobert P Hanzlik
Nov 14, 2013·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Susan S Schiffman, Kristina I Rother
Mar 3, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hideo TakakusaSidney D Nelson
Jul 17, 2004·Chemical & Pharmaceutical Bulletin·Toshimasa TanakaYoshio Yamamoto
Nov 27, 2009·The Journal of Veterinary Medical Science·Yasuhiro UnoHiroshi Yamazaki
Jun 9, 2001·Biochemical and Biophysical Research Communications·J A Neff, D E Moody
Feb 3, 2007·Expert Opinion on Drug Metabolism & Toxicology·Robert J RileyRichard Weaver
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Jul 7, 2007·Critical Reviews in Toxicology·Yasuhiro Masubuchi, Toshiharu Horie
Jul 2, 2005·Critical Reviews in Toxicology·Jennie L WalgrenDavid C Thompson
Mar 8, 2005·Drug Metabolism Reviews·Shufeng ZhouYu-Zong Chen
Sep 5, 2002·Journal of Pharmaceutical Sciences·Caiping Yao, René H Levy
May 23, 2007·British Journal of Clinical Pharmacology·David J ElliotJohn O Miners
Oct 4, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xiao-Xia YangShu-Feng Zhou
Mar 14, 2000·The Journal of Pharmacy and Pharmacology·M MizugakiK Narisawa
Sep 5, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Suzanne TayPeter M Rademacher
Apr 7, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shintaro NakayamaOsamu Okazaki
Jun 10, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yiding HuDavid C Thompson
Oct 23, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·John P O'DonnellR Scott Obach
Mar 24, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Helinä KahmaJanne T Backman
Sep 9, 2004·Chemical Reviews·Bernard MeunierSason Shaik
Jul 28, 2021·American Journal of Human Genetics·Clara J AmorosiMaitreya J Dunham
Mar 19, 2002·Chemical Research in Toxicology·Deepak K DalvieJohn P O'Donnell
Oct 7, 1998·Chemical Research in Toxicology·B K ParkN R Kitteringham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.